Aligos Therapeutics, Inc. (ALGS)
NASDAQ·Healthcare·Biotechnology
$5.16
-3.19%
Mkt Cap $43.23M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$20.00
Range $20.00 – $20.00
Implied Upside
+287.6%
Consensus $20.00 vs current $5.16
NASDAQ·Healthcare·Biotechnology
$5.16
-3.19%
Mkt Cap $43.23M
No recent rating data.
Price Target (4 analysts)
$20.00
Range $20.00 – $20.00
+287.6%
Consensus $20.00 vs current $5.16